Inventor · disambiguated record
Jonathan Weyne
Also filed as: WEYNE JONATHAN
1 granted patent·4 pending applications·0 citations·filing 2020–2024
13Inventor score
Files withREGENERON PHARMA5
Top patents by PatentIndex Score
5 records- 0168US2025115918A1Treatment Of Uveitis With Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0262US12157891B2Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitorsREGENERON PHARMA·Filed 2022·Granted Dec 3, 2024·0 cites·9 claims
- 0360US2024175027A1Anti-c5 antibody/c5 irna co-formulations and combination therapiesREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0459US2024238384A1Treatment Of B27-Negative Uveitis With Inositol Polyphosphate Multikinase (IPMK) Therapeutic Agents Or Indoleamine 2,3-dioxygenase 2 (IDO2) AgonistsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0545US2021139573A1Dosing regimens for treating or preventing c5-associated diseasesREGENERON PHARMA·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonathan Weyne files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →